Portfolio of Genomics Stocks
Genomics includes agrigenomics, bacterial genomics, bioinformatics, cancer genomics, diagnostics, drug discovery, equipment, pharmacogenomics and research.
Here is a table of 10 genomics stocks.
| 10 Genomics Stocks | ||
|---|---|---|
Name | Symbol | Recent Prices |
| Agilent Technologies | A | |
| Alnylam Pharmaceuticals | ALNY | |
| CRISPR Therapeutics | CRSP | |
| Editas Medicine | EDIT | |
| Exact Sciences | EXAS | |
| Illumina | ILMN | |
| Ionis Pharmaceuticals | IONS | |
| Myriad Genetics | MYGN | |
| QIAGEN N.V. | QGEN | |
| Sangamo Therapeutics | SGMO | |
| Price charts from Alpha Vantage as of most recent close. | ||
Portfolio Values
To inspect the performance of the Genomics Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.The 7 stocks included in the portfolio computations are: A, ALNY, EXAS, ILMN, MYGN, QGEN and SGMO. The current value of the portfolio assumes that $1,428.57 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. The 3 stocks excluded from the portfolio computations because of insufficient price data are: CRSP, EDIT and IONS.
The current value of a $10,000 investment is $47,963. The percent return is 379.63%. The annualized return is 36.83%.
Portfolio Value Chart for Last 100 Daily Closes
Values of User-Selected Sample Portfolios: Discover the Most and Least Profitable Sample Portfolios
Related Portfolios
Portfolio of Gene Editing (CRISPR) Stocks
Portfolio of Genetic Testing Stocks
Portfolio of Stem Cell Stocks